Sanjay Subramanian's most recent trade in Inozyme Pharma Inc was a trade of 6,813 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO & Head of BD | Grant, award, or other acquisition of securities at price $ 0.74 per share. | 25 Jun 2025 | 6,813 | 39,701 | - | 0.7 | 5,042 | Common Stock |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO & Head of BD | Grant, award, or other acquisition of securities at price $ 0.77 per share. | 31 Mar 2025 | 2,490 | 32,888 | - | 0.8 | 1,917 | Common Stock |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 145,000 | 145,000 | - | - | Stock Option (right to buy) | |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 38,500 | 38,500 | - | - | Restricted Stock Units | |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 165,000 | 165,000 | - | - | Stock Option (right to buy) | |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 2.21 per share. | 31 Mar 2023 | 979 | 28,079 | - | 2.2 | 2,164 | Common Stock |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 135,000 | 135,000 | - | - | Stock option (right to buy) | |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 19 Apr 2022 | 27,100 | 27,100 | - | 3.7 | 99,999 | Common Stock |
| Inozyme Pharma Inc | Sanjay Subramanian | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 180,000 | 180,000 | - | - | Stock option (right to buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 454,007 | 454,007 | - | - | Stock Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 125,534 | 161,125 (0%) | 0% | 0 | Common Stock | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 35,560 | 35,560 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 26 Oct 2021 | 10,000 | 35,591 (0%) | 0% | 11.1 | 110,700 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.96 per share. | 15 Oct 2021 | 7,990 | 45,591 (0%) | 0% | 10.0 | 79,580 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 7,990 | 7,990 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.19 per share. | 15 Oct 2021 | 7,990 | 53,581 (0%) | 0% | 2.2 | 17,498 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 16 Aug 2021 | 30,000 | 75,591 (0%) | 0% | 0.3 | 10,200 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 30,000 | 246,170 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 16 Aug 2021 | 30,000 | 45,591 (0%) | 0% | 7.2 | 216,600 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 15 Jul 2021 | 31,086 | 45,591 (0%) | 0% | 6.7 | 208,276 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 31,086 | 276,170 | - | - | Options (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 15 Jul 2021 | 31,086 | 76,677 (0%) | 0% | 0.3 | 10,569 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 15 Jun 2021 | 31,000 | 45,591 (0%) | 0% | 7 | 217,000 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 31,000 | 307,256 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 15 Jun 2021 | 31,000 | 76,591 (0%) | 0% | 0.3 | 10,540 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.34 per share. | 14 May 2021 | 31,000 | 76,591 (0%) | 0% | 0.3 | 10,540 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 31,000 | 338,256 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 14 May 2021 | 31,000 | 45,591 (0%) | 0% | 8.2 | 253,673 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.98 per share. | 29 Apr 2021 | 7,990 | 45,591 (0%) | 0% | 11.0 | 87,730 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 7,990 | 15,980 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.19 per share. | 29 Apr 2021 | 7,990 | 53,581 (0%) | 0% | 2.2 | 17,498 | Common Stock |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2021 | 35,591 | 71,183 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Sanjay Subramanian | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 29 Jan 2021 | 35,591 | 45,591 (0%) | 0% | 0.5 | 18,151 | Common Stock |